Monocyte/Macrophages: Unexpected Allies in the Fight Against Arterial Thrombosis?

References
1 Goldin M, Koulas I, Weitz JI, Spyropoulos AC. State-of-the-art mini review: dual-pathway inhibition to reduce arterial and venous thromboembolism. Thromb Haemost 2022; 122 (08) 1279-1287
2 Vilahur G, Fuster V. Interplay between platelets and coagulation: from protective haemostasis to pathological arterial thrombosis. Eur Heart J 2025; 46 (05) 413-423
3 Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Intern Med 2014; 276 (06) 618-632
4 Kral-Pointner JB, Haider P, Szabo PL. et al. Reduced monocyte and neutrophil infiltration and activation by P-selectin/CD62P inhibition enhances thrombus resolution in mice. Arterioscler Thromb Vasc Biol 2024; 44 (04) 954-968
5 Sachetto ATA, Mackman N. Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation. Thromb Haemost 2023; 123 (11) 1017-1033
6 Rolling CC, Sowa MA, Wang TT. et al. P2Y12 inhibition suppresses proinflammatory platelet-monocyte interactions. Thromb Haemost 2023; 123 (02) 231-244
7 Kimball AS, Obi AT, Luke CE. et al. Ly6CLo monocyte/macrophages are essential for thrombus resolution in a murine model of venous thrombosis. Thromb Haemost 2020; 120 (02) 289-299
8 Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res 2002; 53 (02) 313-325
9 Lee K, Cha M-J, Kwon I. et al. Monocyte/macrophage infiltration in thrombus and outcomes of stroke patients with monocyte/macrophage dominant thrombus. Thromb Haemost 2025; 125 (10) 1023-1034
10 Jang HJ, Schellingerhout D, Kim J, Chung J, Kim DE. Towards a biomarker for acute arterial thrombosis using complete blood count and white blood cell differential parameters in mice. Sci Rep 2023; 13 (01) 4043
11 Heusch G, Kleinbongard P. The spleen in ischaemic heart disease. Nat Rev Cardiol 2025; 22 (07) 497-509
12 Ramos-Regalado L, Alcover S, Badimon L, Vilahur G. The influence of metabolic risk factors on the inflammatory response triggered by myocardial infarction: bridging pathophysiology to treatment. Cells 2024; 13 (13) 1125
13 Hristov M, Weber C. Monocyte subsets in cardiovascular disease: a biomarker perspective. Thromb Haemost 2025; 125 (02) 93-96
14 Pan S, Kleppe LS, Witt TA, Mueske CS, Simari RD. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis. Thromb Haemost 2004; 92 (03) 495-502
15 Wang L, Miller C, Swarthout RF, Rao M, Mackman N, Taubman MB. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood 2009; 113 (03) 705-713
16 Rehill AM, Leon G, McCluskey S. et al. Glycolytic reprogramming fuels myeloid cell-driven hypercoagulability. J Thromb Haemost 2024; 22 (02) 394-409
17 Niemann M, Gaudron PD, Bijnens B. et al. Differentiation between fresh and old left ventricular thrombi by deformation imaging. Circ Cardiovasc Imaging 2012; 5 (05) 667-675